12 results
8-K
EX-99.2
SCTL
Societal CDMO Inc
8 Nov 23
Societal CDMO Reports Third Quarter 2023 Financial Results
4:11pm
of the product may vary significantly. The graph does not assume new customer additions or attrition. The information provided is illustrative only … – Est. 2023 (1) Size of Icon Represents 2023 Revenue Value $1 million$15 million $0.5 million Not Risk Adj for Attrition Lannett Teva Advanz
8-K
EX-99.2
SCTL
Societal CDMO Inc
14 Aug 23
Societal CDMO Reports Second Quarter 2023 Financial Results
4:28pm
of the product may vary significantly. The graph does not assume new customer additions or attrition. The information provided is illustrative only … – Est. 2023 (1) Size of Icon Represents 2023 Revenue Value $1 million$15 million $0.5 million Not Risk Adj for Attrition Lannett Teva Advanz Clinical
8-K
EX-99.2
z2vq3h
10 May 23
Societal CDMO Reports First Quarter 2023 Financial Results
4:22pm
8-K
EX-99.1
1bsdc0vvfnqx1s3trvtf
12 Dec 22
Entry into a Material Definitive Agreement
6:49am
8-K
EX-99.1
brj871job51i4pl
16 Nov 22
Regulation FD Disclosure
9:24am
8-K
EX-99.1
0rgeck
8 Jun 22
Corporate Presentation May 2022
7:35am
8-K
EX-99.2
3mv5hz2ohkui9l
11 May 22
Societal CDMO Reports First Quarter 2022 Financial Results
4:09pm
8-K
EX-99.2
zad0dyhg42cblqpuuv
1 Mar 22
Recro Reports Fourth Quarter and Year End 2021 Financial Results
4:12pm
8-K
EX-99.2
3jxh4p7kr9uhh nq
19 Aug 21
Vida Strategic Partners
9:01am
- Prev
- 1
- Next